• Save
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
509
On Slideshare
508
From Embeds
1
Number of Embeds
1

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 1

http://www.safemedicines.org 1

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. PSM India Presentation Bejon Misra Founder and Head Partnership for Safe Medicines India
  • 2. What are the goals of PSM India? • To raise public awareness of the harm to patient safety caused by spurious drugs • To raise consumer and distributor awareness of the existence and extent of spurious drugs • To work collaboratively with the medical community • To educate Indian consumers on the importance of drug quality, how to identify suspected spurious drugs, and what actions to take when encountering a suspected case • To educate community healthcare practitioners in drugstores and health centers on the problem of spurious drugs and what role they can play to lessen the problem 2
  • 3. PSM India’s International Workshop • Collaboration with ✦ ✦ ✦ Government of India World Health Organization Partnership for Safe Medicines India • Insuring Patient Safety Prevails over Commercial Interest • Regaining Consumer Confidence 3
  • 4. Study: The Extent of Spurious Drugs in the Supply Chain of Indian Market • 10,000 Manufacturers – How many meet GMP? – Small scale manufacturers are the greatest risk – Better to shape up than face the consequences 4
  • 5. Goals of the Study: • To enable assessment of the drugs available in India for compliance with regulations pertaining to pharmaceopoeial standards and spurious drugs as defined in the regulation. • To understand the extent of the spurious drug problem across the entire country. Medicines to be Evaluated 348 Essential Drugs –TB, malaria, HIV, cancer, diabetes, infection, all major therapeutic areas 5
  • 6. Expanding to Local Indian States • design a strategy to implement the use of detection and authentication technologies to make spurious and unsafe medicines easily detectable • take prompt action against all such manufacturers who violate the laws and standards of our country by working closely with the State Regulators and law enforcers 6
  • 7. Coming Up at 1:15pm • Panel 3 Bringing Criminals to Justice Across Jurisdictions